Literature DB >> 10934973

How long are TB patients infectious?

D Ahmad, W K Morgan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10934973      PMCID： PMC80197     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  Tuberculosis: 11. Nosocomial disease.

Authors:  K Schwartzman; D Menzies
Journal:  CMAJ       Date:  1999-11-16       Impact factor: 8.262

2.  Tuberculosis disseminators. A study of the variability of aerial infectivity of tuberculous patients.

Authors:  L SULTAN; W NYKA; C MILLS; F O'GRADY; W WELLS; R L RILEY
Journal:  Am Rev Respir Dis       Date:  1960-09

3.  Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients.

Authors:  R L RILEY; C C MILLS; F O'GRADY; L U SULTAN; F WITTSTADT; D N SHIVPURI
Journal:  Am Rev Respir Dis       Date:  1962-04

4.  The scope of the controlled clinical trial, illustrated by studies of pulmonary tuberculosis.

Authors:  W Fox
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

5.  The chemotherapy and epidemiology of tuberculosis. Some findings of general applicability from the Tuberculosis Chemotherapy Centre, Madras.

Authors:  W FOX
Journal:  Lancet       Date:  1962-09-08       Impact factor: 79.321
  5 in total
  6 in total

1.  Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes.

Authors:  Blanca I Restrepo; Susan P Fisher-Hoch; Brian Smith; Sangchoon Jeon; Mohammad H Rahbar; Joseph B McCormick
Journal:  Am J Trop Med Hyg       Date:  2008-10       Impact factor: 2.345

2.  Respiratory isolation for tuberculosis: the experience of Indigenous peoples on the Canadian prairies.

Authors:  M Mayan; T Robinson; R Gokiert; M Tremblay; S Abonyi; R Long
Journal:  Public Health Action       Date:  2017-12-21

3.  Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.

Authors:  Judith Mwansa-Kambafwile; Boitumelo Maitshotlo; Andrew Black
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

4.  Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.

Authors:  S Orlando; I Triulzi; F Ciccacci; I Palla; L Palombi; M C Marazzi; M Giuliano; M Floridia; S Mancinelli; E Mutemba; G Turchetti
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

5.  Initial loss to follow up among tuberculosis patients: the role of Ward-Based Outreach Teams and short message service (SMS) technology (research proposal).

Authors:  Judith R M Mwansa-Kambafwile; Charles Chasela; Nazir Ismail; Colin Menezes
Journal:  BMC Res Notes       Date:  2019-11-08

6.  Barriers to tuberculosis case finding in primary and secondary health facilities in Ghana: perceptions, experiences and practices of healthcare workers.

Authors:  Joyce B Der; Alison D Grant; Daniel Grint; Clement T Narh; Frank Bonsu; Virginia Bond
Journal:  BMC Health Serv Res       Date:  2022-03-19       Impact factor: 2.655
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.